Focusing on antitrust, intellectual property, and high-stakes litigation, our extensive teams in the U.S. possess deep knowledge and client-side experience across a range of sectors, including technology, healthcare, life sciences, and consumer products.
- Our track record of obtaining global clearance of combinations of significant rivals has built Axinn’s reputation as a “go-to” firm for strategic mergers and acquisitions
- We are lead defense counsel to some of the world’s largest companies in high-stakes treble damages, class action, and multi-district litigations, as well as federal and state investigations
- We are creative, tenacious, and experienced trial lawyers who deliver favorable results in must-win cases
- Over 400 years of collective IP experience
- Extensive experience in patent and trade secret trials, appeals, and U.S. Patent Office practice, including IPRs
Explore Our Practices
Featured Viewpoints
Featured Viewpoints
DOJ Settles Challenge to UnitedHealth/Amedisys Merger: Three Key Takeaways for M&A Antitrust Under Trump
Entresto Trade Dress Dispute: No Injunctive Relief for Novartis
Hanging in the Balance: Supreme Court Declines to Decide the Uninjured Class Member Question in Labcorp v. Davis
New Incentives, New Rewards: What You Need to Know About the Antitrust Division’s First-Ever Whistleblower Rewards Program
Recent Decision Shows the Heavy Burden of Actual Malice in Defamation Suits
FTC Peeling Back the Layers of the Orange Book
Wynn v. The Associated Press, et al.: A Recent Petition for a Writ of Certiorari Highlights Challenges to New York Times v. Sullivan and Anti-SLAPP Laws
